The U.S. Food and Drug Administration today issued a draft guidance for sponsors seeking approval of human gene therapy products involving genome editing technologies.
Healthcare
FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development
Source: FDA Press Releases — US Government, Public Domain